Last reviewed · How we verify
Product 55394
Product 55394 is a topical gel used to treat moderate to severe acne.
Product 55394 is a topical gel used to treat moderate to severe acne. Used for Moderate to severe acne.
At a glance
| Generic name | Product 55394 |
|---|---|
| Sponsor | Medicis Global Service Corporation |
| Drug class | topical retinoid |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
It works by reducing inflammation and preventing the formation of new acne lesions. The exact mechanism of action is not fully understood, but it is thought to involve the inhibition of inflammatory pathways.
Approved indications
- Moderate to severe acne
Common side effects
- Skin irritation
- Dry skin
- Redness
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Product 55394 CI brief — competitive landscape report
- Product 55394 updates RSS · CI watch RSS
- Medicis Global Service Corporation portfolio CI